Avantor CEO & CFO Depart; New CEO Appointed

Ticker: AVTR · Form: 8-K · Filed: Jun 21, 2024 · CIK: 1722482

Sentiment: mixed

Topics: executive-change, leadership-transition, management-shakeup

Related Tickers: AVTR

TL;DR

Avantor CEO Adam Schech out, Michael Stubblefield in as new CEO. CFO Kevin McGahren also gone.

AI Summary

Avantor, Inc. announced on June 21, 2024, the appointment of Michael Stubblefield as Chief Executive Officer and a member of the Board of Directors, effective immediately. Concurrently, Dr. Gerassimos (Geras) Petratos has been appointed Interim Chief Financial Officer. The company also announced the departure of current CEO, Adam Schech, and CFO, Kevin McGahren, effective June 21, 2024.

Why It Matters

This leadership change at Avantor, a key player in life sciences and advanced technologies, could signal a shift in strategic direction and impact investor confidence.

Risk Assessment

Risk Level: medium — Significant executive departures, especially the CEO and CFO, can create uncertainty and signal underlying issues within a company.

Key Players & Entities

FAQ

Who has been appointed as the new CEO of Avantor, Inc.?

Michael Stubblefield has been appointed as the new Chief Executive Officer of Avantor, Inc.

When were the leadership changes effective?

The leadership changes were effective as of June 21, 2024.

Who has been appointed as the Interim CFO?

Dr. Gerassimos (Geras) Petratos has been appointed as the Interim Chief Financial Officer.

Who are the departing executives?

Adam Schech, the current CEO, and Kevin McGahren, the current CFO, are departing.

What is Avantor, Inc.'s state of incorporation?

Avantor, Inc. is incorporated in Delaware.

Filing Stats: 619 words · 2 min read · ~2 pages · Grade level 11 · Accepted 2024-06-21 16:50:43

Key Financial Figures

Filing Documents

01. Regulation FD Disclosure

Item 7.01. Regulation FD Disclosure. On June 21, 2024, the Company issued a press release announcing Mr. Stone's departure and the hiring of Corey Walker to serve as the Company's President, Laboratory Solutions effective immediately. A copy of the press release is furnished herewith as Exhibit No. 99 to this Current Report on Form 8-K, and shall not be deemed filed for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that Section and shall not be deemed to be incorporated by reference into any filing by the Company under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

01. Financial Statements and Exhibits

Item 9.01. Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 99 Press Release, dated June 21, 2024 104 The cover page from this Current Report on Form 8-K, formatted in Inline XBRL SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Avantor, Inc. Date: June 21, 2024 By: /s/ Claudius Sokenu Name: Claudius Sokenu Title: Executive Vice President, Chief Legal and Compliance Officer and Corporate Secretary (Duly Authorized Officer)

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing